Diagnostics

ZEISS Industrial Quality Solutions Transforms its Go-to-Market-Strategy in Canada to Drive Customer Excellence

MAPLE GROVE, Minn., Dec. 4, 2024 /PRNewswire/ -- ZEISS Industrial Quality Solutions, the global leader in cutting-edge metrology and inspection technologies…

1 year ago

Ketryx Announces DeepHealth Selected Its Software to Accelerate AI-Powered Health Informatics Innovation

CAMBRIDGE, Mass., Dec. 4, 2024 /PRNewswire/ -- Ketryx announced today that DeepHealth, Inc., a global leader in AI-powered health informatics and…

1 year ago

Codetta Bio Welcomes Paul McEwan and Mitch Levine as Independent Board Members

MORRISVILLE, N.C., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Codetta Bio, a leader in integrated multi-omics solutions, is proud to announce…

1 year ago

WERFEN EXPANDS HEMOSTASIS AND ACUTE CARE DIAGNOSTICS TECHNOLOGY CENTER IN BEDFORD, MA

-Drives Continuous Innovation in Specialized Diagnostics to Power Patient Care- BEDFORD, Mass., Dec. 3, 2024 /PRNewswire/ -- Werfen today announced…

1 year ago

Fabric Named Top 50 Digital Health Company by CB Insights

Fabric recognized for clinical intelligence, workflow automation, and consumer outcomes. NEW YORK, Dec. 3, 2024 /PRNewswire/ -- CB Insights today named Fabric to…

1 year ago

Adonis Named to the 2024 CB Insights’ List of the 50 Most Innovative Digital Health Startups

Adonis recognized for achievements in improving healthcare financial outcomes and patient experiences through AI. NEW YORK, Dec. 3, 2024 /PRNewswire/…

1 year ago

Quest Diagnostics Launches Health Coaching on questhealth.com to Help Individuals Take Control of Their Health

New service takes the guesswork out of achieving one's health goals by empowering individuals to pair Quest lab results with…

1 year ago

Avails Medical announces the commencement of U.S. Pilot Trial for the eAST™ system

MENLO PARK, Calif., Dec. 3, 2024 /PRNewswire/ -- Avails Medical, Inc., a leader in rapid, automated, and fully electrical antibiotic susceptibility…

1 year ago

Lisata Therapeutics and Kuva Labs Announce Global License Agreement for Solid Tumor Imaging

License provides Lisata’s innovative certepetide targeting agent for use with Kuva’s NanoMark™ MR imaging platform to advance non-invasive, high-precision cancer…

1 year ago

Adaptive Biotechnologies Announces Over 65 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 66th ASH Annual Meeting

SEATTLE, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to…

1 year ago